RESULTS	When considering a post-hoc combined endpoint of deep-vein thrombosis and pulmonary embolism , significantly fewer events occurred in the enoxaparin group than in the unfractionated-heparin group ( 2.7 % vs. 8.8 % ; p = 0.026 ) .\